Systematic analysis of design and stratification for phase III trials in first-line advanced non-small cell lung cancer

Komiya Takefumi; Perez Raymond P.; Erickson Kirsten D.; Huang Chao H.

首页> 外文期刊>Thoracic cancer. >Systematic analysis of design and stratification for phase III trials in first-line advanced non-small cell lung cancer

【24h】

Systematic analysis of design and stratification for phase III trials in first-line advanced non-small cell lung cancer

机译：一线晚期非小细胞肺癌三期试验设计和分层的系统分析

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background: A recent study reviewed phase III trials of first-line advanced non-small cell lung cancer (NSCLC) conducted from 1981 to 2010, and provided trends in the study outcome. However, such trials have never been analyzed in detail for design and stratification factors.

机译：背景：最近的一项研究回顾了从1981年至2010年进行的一线晚期非小细胞肺癌（NSCLC）的III期试验，并提供了研究结果的趋势。但是，从未对此类试验的设计和分层因素进行详细分析。

著录项

来源
《Thoracic cancer.》 |2016年第1期|共6页
作者
Komiya Takefumi; Perez Raymond P.; Erickson Kirsten D.; Huang Chao H.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词
First-line; non-small cell lung cancer; phase III;

机译：一线;非小细胞肺癌;III期;

相似文献

外文文献
中文文献
专利

1. Systematic analysis of design and stratification for phase III trials in first-line advanced non-small cell lung cancer [J] . Komiya Takefumi, Perez Raymond P., Erickson Kirsten D., Thoracic cancer. . 2016,第1期

机译：一线晚期非小细胞肺癌三期试验设计和分层的系统分析
2. Gefitinib vs. chemotherapy as first-line therapy in advanced non-small cell lung cancer: meta-analysis of phase III trials. [J] . Ku GY, Haaland BA, de Lima Lopes G Jr Lung cancer: Journal of the International Association for the Study of Lung Cancer . 2011,第3期

机译：吉非替尼vs.化疗作为晚期非小细胞肺癌的一线治疗：III期临床试验的荟萃分析。
3. Efficacy and safety of cisplatin/pemetrexed versus cisplatin/gemcitabine as first-line treatment in East Asian patients with advanced non-small cell lung cancer: results of an exploratory subgroup analysis of a phase III trial. [J] . Yang CH, Simms L, Park K, Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2010,第5期

机译：顺铂/培美曲塞与顺铂/吉西他滨作为一线治疗在东亚晚期非小细胞肺癌患者中的疗效和安全性：III期临床试验亚组分析的结果。
4. A Deep Learning-Facilitated Radiomics Solution for the Prediction of Lung Lesion Shrinkage in Non-Small Cell Lung Cancer Trials [C] . Antong Chen, Jennifer Saouaf, Bo Zhou, IEEE International Symposium on Biomedical Imaging . 2020

机译：在非小细胞肺癌试验中用于预测肺病变萎缩的深度学习促进放射组学解决方案
5. Predictive Biomarkers of the Efficacy of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Treating Advanced Non-small Cell Lung Cancer: A Systematic Review of Randomized Controlled Trials [D] . Yang, Zuyao. 2014

机译：表皮生长因子受体酪氨酸激酶抑制剂治疗晚期非小细胞肺癌疗效的预测生物标志物：随机对照试验的系统评价。
6. Systematic analysis of design and stratification for phase III trials in first‐line advanced non‐small cell lung cancer [O] . Takefumi Komiya, Raymond P. Perez, Kirsten D. Erickson, 2016

机译：一线晚期非小细胞肺癌三期试验设计和分层的系统分析
7. Efficacy and Safety of Cisplatin/Pemetrexed Versus Cisplatin/Gemcitabine as First-Line Treatment in East Asian Patients with Advanced Non-small Cell Lung Cancer: Results of an Exploratory Subgroup Analysis of a Phase III Trial [O] . Chih-Hsin Yang, Lorinda Simms, Keunchil Park, 2010

机译：顺铂/聚氯胺蛋白/芽蛋白/吉西他滨的疗效和安全性是东亚患者先进的非小细胞肺癌的一线治疗：III期试验的探索性亚组分析的结果

Systematic analysis of design and stratification for phase III trials in first-line advanced non-small cell lung cancer

摘要

著录项

相似文献

相关主题

期刊订阅